There are 2789 resources available
1750P - Molecular genotyping in refractory thyroid cancers: Results of a European survey
Presenter: Christelle de la Fouchardiere
Session: ePoster Display
1751P - Real-world study of REarranged during Transfection [RET] testing in patients [pts] with medullary thyroid cancer [MTC] in Europe [EU5]
Presenter: Rhys Williams
Session: ePoster Display
1752P - Characteristics and treatment [tx] patterns in patients [pts] with medullary thyroid cancer [MTC] with and without REarranged during Transfection [RET] mutations in Europe
Presenter: Alex Rider
Session: ePoster Display
1753P - REarranged during Transfection [RET] gene fusion testing patterns for patients [pts] with papillary thyroid cancer [PTC] across five European countries
Presenter: Michael Kostikas
Session: ePoster Display
1754P - Current picture of Anaplastic Thyroid Cancer patients' care and meetable needs: A survey of 94 institutions from the EORTC Endocrine and Head and Neck Cancer Groups
Presenter: Laura Locati
Session: ePoster Display
1855P - Logistic and documentary factors influencing reasonable tumorboard decisions
Presenter: Lars Galonska
Session: ePoster Display
1756TiP - Dabrafenib and trametinib combination as a neoadjuvant strategy in BRAF-positive anaplastic thyroid cancer (ANAPLAST-NEO)
Presenter: Yuliya Mikheeva
Session: ePoster Display
1857P - Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial
Presenter: Alice Avancini
Session: ePoster Display
1764P - A dose and time-dependent inhibitory effect of thymoquinone on inflammasome pathway in hormone receptor positive breast cancer: A novel personalized adjuvant therapy
Presenter: Sawsan Elgohary
Session: ePoster Display
1765P - The lack of KRAS variation and its therapeutic implication in MSI-H colorectal cancer with NTRK fusion
Presenter: Chenlu Zhang
Session: ePoster Display